Cardiac dose reduction with deep inspiration breath hold for left-sided breast cancer radiotherapy patients with and without regional nodal irradiation

Radiation Oncology

Tien Phan³  Alana Hudson⁴  Wendy Smith⁴  Haocheng Li¹  Daphne Walrath⁵  Karen Long⁵  Leigh Conroy²  Rosanna Yeung³ 

[1] Departments of Oncology and Community Health Sciences, University of Calgary, 2500 University Dr NW, Calgary T2N 1 N4, Alberta, Canada;Department of Physics & Astronomy, University of Calgary, 2500 University Dr NW, Calgary T2N 1 N4, Alberta, Canada;Division of Radiation Oncology, Department of Oncology, University of Calgary,, 2500 University Dr NW, Calgary T2N 1 N4, Alberta, Canada;Division of Medical Physics, Department of Oncology, University of Calgary, 2500 University Dr NW, Calgary T2N 1 N4, Alberta, Canada;Department of Radiation Therapy, Tom Baker Cancer Centre, 1331 29 Street Northwest, Calgary T2N 4 N2, AB, Canada

关键词: Cardiac dose;    Patient selection;    Regional nodal irradiation;    Dosimetry;    Deep inspiration breath hold;    Breast cancer;   

Others  :  1228443
DOI  :  10.1186/s13014-015-0511-8

 received in 2015-06-08, accepted in 2015-09-15,  发布年份 2015

【 摘 要 】

Background

Deep inspiration breath hold (DIBH) reduces heart and left anterior descending artery (LAD) dose during left-sided breast radiation therapy (RT); however there is limited information about which patients derive the most benefit from DIBH. The primary objective of this study was to determine which patients benefit the most from DIBH by comparing percent reduction in mean cardiac dose conferred by DIBH for patients treated with whole breast RT ± boost (WBRT) versus those receiving breast/chest wall plus regional nodal irradiation, including internal mammary chain (IMC) nodes (B/CWRT + RNI) using a modified wide tangent technique. A secondary objective was to determine if DIBH was required to meet a proposed heart dose constraint of D _mean  < 4 Gy in these two cohorts.

Methods

Twenty consecutive patients underwent CT simulation both free breathing (FB) and DIBH. Patients were grouped into two cohorts: WBRT (n = 11) and B/CWRT + RNI (n = 9). 3D-conformal plans were developed and FB was compared to DIBH for each cohort using Wilcoxon signed-rank tests for continuous variables and McNemar’s test for discrete variables. The percent relative reduction conferred by DIBH in mean heart and LAD dose, as well as lung V ₂₀were compared between the two cohorts using Wilcox rank-sum testing. The significance level was set at 0.05 with Bonferroni correction for multiple testing.

Results

All patients had comparable target coverage on DIBH and FB. DIBH statistically significantly reduced mean heart and LAD dose for both cohorts. Percent reduction in mean heart and LAD dose with DIBH was significantly larger in the B/CWRT + RNI cohort compared to WBRT group (relative reduction in mean heart and LAD dose: 55.9 % and 72.1 % versus 29.2 % and 43.5 %, p < 0.02). All patients in the WBRT group and five patients (56 %) in the B/CWBRT + RNI group met heart D _mean<4 Gy with FB. All patients met this constraint with DIBH.

Conclusions

All patients receiving WBRT met D _meanHeart < 4 Gy on FB, while only slightly over half of patients receiving B/CWRT + RNI were able to meet this constraint in FB. DIBH allowed a greater reduction in mean heart and LAD dose in patients receiving B/CWRT + RNI, including IMC nodes than patients receiving WBRT. These findings suggest greatest benefit from DIBH treatment for patients receiving regional nodal irradiation.

【 授权许可】

   
2015 Yeung et al.

【 图 表 】

Fig. 1.

【 参考文献 】

• [1]Clarke M, Collins R, Darby S, Davies C, Elphinstone P, Evans V et al.. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomized trials. Lancet. 2005; 366:2087-2106.
• [2]McGale P, Taylor C, Correa C, Cutter D, Duana F et al.. Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials. Lancet. 2014; 383:2127-2135.
• [3]Paszat LF, Mackillop WJ, Groome PA, Schulze K, Holowaty E. Mortality from myocardial infarction following post-lumpectomy radiotherapy for breast cancer: a population-based study in Ontario, Canada. Int J Radiat Oncol Biol Phys. 1999; 43:755-762.
• [4]Darby SC, Ewertz M, McGale P, Bennet AM, Blom-Goldman U, Bronnum D et al.. Risk of ischemic heart disease in women after radiotherapy for breast cancer. N Eng J Med. 2013; 368:987-998.
• [5]Giordano SH, Kuo YF, Freeman JL, Buchholz TA, Hortobaqyi GN, Goodwin JS. Risk of cardiac death after adjuvant radiotherapy for breast cancer. J Natl Cancer Inst. 2005; 97:419-424.
• [6]Shapiro CL, Hardernbergh PH, Gelman R, Blanks D, Hauptman P, Recht A et al.. Cardiac effects of adjuvant doxorubicin and radiation therapy in breast cancer patients. J Clin Oncol. 1998; 16:3493-3501.
• [7]Hjelstuen MHB, Mjaaland I, Vikström J, Dybvik KI. Radiation during deep inspiration allows loco-regional treatment of left breast and axillary-, supraclavicular and internal mammary lymph nodes without compromising target coverage or dose restrictions to organs at risk. Acta Oncol. 2012; 51:333-344.
• [8]Nissen HD, Appelt AL. Improved heart, lung, and target dose with deep inspiration breath hold in a large clinical series of breast cancer patients. Radiother Oncol. 2013; 106:28-32.
• [9]Korreman SS, Pedersen AN, Nøttrup TJ, Specht L, Nyström H. Breathing adapted radiotherapy for breast cancer: comparison of free breathing gating with the breath-hold technique. Radiother Oncol. 2005; 76:311-318.
• [10]Pedersen AN, Korreman S, Nyström H, Specht L. Breathing adapted radiotherapy of breast cancer: reduction of cardiac and pulmonary doses using voluntary inspiration breath hold. Radiother Oncol. 2004; 72:53-60.
• [11]Remouchamps VM, Vicini FA, Sharpe MB, Kestin LL, Martinez AA, Wong JW. Significant reductions in heart and lung doses using deep inspiration breath hold with active breathing control and intensity modulated radiation therapy for patients treated with locoregional breast irradiation. Int J Radiat Oncol Biol Phys. 2003; 55:392-406.
• [12]Hayden A, Rains M, Tiver K. Deep inspiration breath hold technique reduces heart dose from radiotherapy for left-sided breast cancer with deep breath-holding. J Med Imaging Radiat Oncol. 2012; 56:464-472.
• [13]Nemoto K, Ogushi M, Nakajima M, Kozuka T, Nose T, Yamashita T. Cardiac-sparing radiotherapy for left breast cancer with deep breath-holding. Jpn J Radiol. 2009; 27:259-263.
• [14]Lu HM, Cash E, Chen MH, Chin L, Manning WJ, Harris J et al.. Reduction of cardiac volume in left-breast treatment field by respiratory maneuvers: a CT study. Int J Radiat Oncol Biol Phys. 2000; 47:895-904.
• [15]Sixel K, Aznar M, Ung Y. Deep inspiration breath hold to reduce irradiated heart volume in breast cancer patients. Int J Radiat Oncol Biol Phys. 2001; 49:199-204.
• [16]Breast NSA, Project B. NSABP Protocol B-51: A randomized phase III clinical trial evaluating post-mastectomy chestwall and regional nodal xrt and post-lumpectomy regional nodal xrt in patients with positive axillary nodes before neoadjuvant chemotherapy who convert to pathologically negative axillary nodes after neoadjuvant chemotherapy. Pittsburgh: NSABP; 2013 [Available at: mtcancer.org/Protocols/B51_Protocol.pdf; cited April 25, 2014].
• [17]Sadaro A, Petruzzelli MF, D’Errico MP, Grimauldi L, Pili G, Portaluri M. Radiation-induced cardiac damage in early left breast cancer patients: risk factors, biological mechanisms, radiobiology, and dosimetric constraints. Radiother Oncol. 2012; 103:133-142.
• [18]Nilsson G, Holmberg L, Carmo H, Duvernoy O, Sjögren I, Lagerqvist B et al.. Distribution of coronary artery stenosis after radiation for breast cancer. J Clin Oncol. 2012; 30:380-386.
• [19]White J, Tai A, Arthur D, Buchholz T, MacDonald S, Marks L, et al. Radiotherapy Oncology Group breast cancer atlas for radiation therapy planning: consensus definitions. [Available at: http://www.rtog.org/LinkClick.aspx?fileticket=vzJFhPaBipE%3d&tabid=23; cited June 15, 2013].
• [20]Marks LB, Hebert ME, Bentel G, Spencer DP, Sherouse GW, Prosnitz LR. To treat or not to treat the internal mammary nodes: a possible compromise. Int J RadiatOncolBiolPhys. 1994; 29:903-909.
• [21]Feng M, Moran JM, Koelling T, Chughtai A, Chan JL, Freedman L et al.. Development and validation of a heart atlas to study cardiac exposure to radiation following treatment for breast cancer. Int J Radiat Oncol Biol Phys. 2011; 79:10-18.
• [22]R Core Team (2015). R: A language and environment for statistical computing. R Foundation for Statistical Computing. Vienna, Austria. http://www.R-project.org. Accessed 01 Sept 2015.
• [23]Gagliardi G, Constine LS, Moiseenko V, Correa C, Pierce LJ, Allen AM et al.. Radiation Dose-Volume Effects in the Heart. Int J Radiat Oncol Biol Phys. 2010; 76(3 Suppl):S77-S85.
• [24]Arthur DW, Arnfield MR, Warwicke LA, Morris MM, Zwicker RD. Internal mammary node coverage: an investigation of presently accepted techniques. Int J Radiat Oncol Biol Phys. 2000; 48:139-146.
• [25]Severin D, Connors S, Thompson H, Rathee S, Stavrev P, Hanson J. Breast radiotherapy with inclusion of internal mammary nodes: a comparison of techniques with three-dimensional planning. Int J Radiat Oncol Biol Phys. 2003; 55:633-644.
• [26]Poortmans P, Struikmans H, Kirkove C, Budach V, Malngon P, Valli MC et al.. Irradiation of the internal mammary and medial supraclavicular lymph nodes in stage I to III breast cancer: 10 years results of the EORTC Radiation Oncology and Breast Cancer Groups phase III trial 22922/10925 [Abstract]. Eur J Cancer. 2013; 47:2.
• [27]Konings AW, Smit Sibinga CT, Aarnoudse MW. Initial events in radiation induced atheromatosis. Damage to intimal cells. Strahlen therapie. 1978; 154:795-800.